Cargando…

Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach

Bisphosphonates are commonly prescribed to inhibit bone loss in patients with osteoporosis, as well as osteopenia, cancer, and Paget's disease of the bone. Recently, scientific literature has addressed a possible relationship between bisphosphonates and osteonecrosis of the jaw (ONJ). It is imp...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: De Ponte, Francesco Saverio (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Milano : Springer Milan : Imprint: Springer, 2012.
Edición:1st ed. 2012.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-88-470-2083-2
003 DE-He213
005 20220126103606.0
007 cr nn 008mamaa
008 111124s2012 it | s |||| 0|eng d
020 |a 9788847020832  |9 978-88-470-2083-2 
024 7 |a 10.1007/978-88-470-2083-2  |2 doi 
050 4 |a RK529-535 
072 7 |a MMDS  |2 bicssc 
072 7 |a MED085020  |2 bisacsh 
072 7 |a MKEP  |2 thema 
082 0 4 |a 617.52059  |2 23 
245 1 0 |a Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach  |h [electronic resource] /  |c edited by Francesco Saverio De Ponte. 
250 |a 1st ed. 2012. 
264 1 |a Milano :  |b Springer Milan :  |b Imprint: Springer,  |c 2012. 
300 |a XIII, 181 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
520 |a Bisphosphonates are commonly prescribed to inhibit bone loss in patients with osteoporosis, as well as osteopenia, cancer, and Paget's disease of the bone. Recently, scientific literature has addressed a possible relationship between bisphosphonates and osteonecrosis of the jaw (ONJ). It is important to note that though the risks for developing ONJ are much higher for cancer patients on intravenous bisphosphonate therapy (used to reduce bone pain), the occurrence of ONJ also in patients treated with oral BF for osteoporosis has been also highlighted, though rarely. On the basis of the large use of BF, of their pharmacokinetics, of the systemic and local risk factors, physicians prescribing them and dental surgeons should be well informed on the various aspects of the problem. Aim of this volume is to offer an update on the current status of prevention, and on the current conservative and surgical treatments. The multidisciplinary approach will be very much appreciated by GP's, the different specialists using bisphosphonates and by dental surgeons. 
650 0 |a Mouth-Surgery. 
650 0 |a Dentistry. 
650 0 |a Hematology. 
650 0 |a Family medicine. 
650 0 |a Pharmacy. 
650 0 |a Radiology. 
650 1 4 |a Oral and Maxillofacial Surgery. 
650 2 4 |a Dentistry. 
650 2 4 |a Hematology. 
650 2 4 |a General Practice and Family Medicine. 
650 2 4 |a Pharmacy. 
650 2 4 |a Radiology. 
700 1 |a De Ponte, Francesco Saverio.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9788847020825 
776 0 8 |i Printed edition:  |z 9788847023017 
776 0 8 |i Printed edition:  |z 9788847039094 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-88-470-2083-2  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)